Yazar "Yavuz, Selim A." için listeleme
-
The Clinical Impact of Low Doses of Dasatinib in Patients with Chronic Myeloid Leukemia
Aksu, Salih; Sahin, Fahri; Uz, Burak; Yavuz, Selim A.; Atay, Hilmi; Kelkitli, Engin; Haznedaroglu, Ibrahim C. (Akad Doktorlar Yayinevi, 2012)We report our experience in 41 patients with chronic phase (CF)-chronic myeloid leukemia (CML) who had discontinued imatinib switched to dasatinib, retrospectively. The CF-CML patients received dasatinib at starting dose ...
